This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

JAMA. 2006;295:1252.

Failure to Disclose Financial Interest: In the Original Contribution entitled "Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients: RIO-North America: A Randomized Controlled Trial" published in the February 15, 2006, issue of JAMA (2006;295:761-775), the following financial disclosure should be added for Julio Rosenstock, MD. On page 774, under "Financial Disclosures," "Dr Rosenstock has received honoraria from Sanofi-Aventis for lectures and for consultant services" should be added right before "No other authors reported financial disclosures."